The 2021 Hybrid Summit covers both small molecules and biologics, new technologies, concepts and case studies in areas such as:
-
Formulation design for poorly soluble compounds
-
The potential of nanotechnology for better deliverability
-
The latest controlled released technologies
-
Improving patient compliance by harnessing data and the latest smart device technology
-
Optimising formulations for continuous manufacturing
-
Overcoming the blood brain barrier and challenges in oral delivery of biologics
-
Reformulation and biosimilars